A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Standard Biotools Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 27,200 shares of LAB stock, worth $49,776. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,200
Previous 12,800 112.5%
Holding current value
$49,776
Previous $22,000 136.36%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.42 - $2.35 $1.19 Million - $1.97 Million
-839,676 Reduced 92.75%
65,670 $126,000
Q2 2024

Aug 14, 2024

BUY
$1.65 - $2.92 $1.49 Million - $2.64 Million
905,346 New
905,346 $1.6 Million
Q4 2023

Feb 14, 2024

SELL
$1.59 - $2.73 $67,107 - $115,222
-42,206 Reduced 37.18%
71,319 $157,000
Q3 2023

Nov 14, 2023

BUY
$1.9 - $3.05 $63,640 - $102,159
33,495 Added 41.85%
113,525 $329,000
Q2 2023

Aug 14, 2023

SELL
$1.47 - $2.56 $49,227 - $85,729
-33,488 Reduced 29.5%
80,030 $154,000
Q1 2023

May 15, 2023

BUY
$1.3 - $2.24 $118,965 - $204,986
91,512 Added 415.85%
113,518 $221,000
Q4 2022

Feb 14, 2023

BUY
$0.93 - $1.52 $9,274 - $15,158
9,973 Added 82.88%
22,006 $25,000
Q3 2022

Nov 14, 2022

SELL
$1.1 - $2.06 $276,372 - $517,570
-251,248 Reduced 95.43%
12,033 $13,000
Q2 2022

Aug 15, 2022

BUY
$1.6 - $3.99 $333,262 - $831,073
208,289 Added 378.76%
263,281 $421,000
Q1 2022

May 16, 2022

SELL
$2.8 - $3.96 $139,034 - $196,633
-49,655 Reduced 47.45%
54,992 $197,000
Q4 2021

Feb 14, 2022

BUY
$3.63 - $6.13 $154,253 - $260,488
42,494 Added 68.37%
104,647 $410,000
Q3 2021

Nov 15, 2021

SELL
$5.5 - $7.41 $189,084 - $254,748
-34,379 Reduced 35.61%
62,153 $410,000
Q2 2021

Aug 16, 2021

SELL
$4.35 - $6.35 $87,004 - $127,006
-20,001 Reduced 17.16%
96,532 $594,000
Q1 2021

May 17, 2021

BUY
$3.94 - $7.09 $221,278 - $398,188
56,162 Added 93.03%
116,533 $527,000
Q4 2020

Feb 16, 2021

SELL
$5.45 - $8.65 $940,315 - $1.49 Million
-172,535 Reduced 74.08%
60,371 $362,000
Q3 2020

Nov 16, 2020

BUY
$4.34 - $11.43 $815,238 - $2.15 Million
187,843 Added 416.85%
232,906 $1.73 Million
Q1 2020

May 15, 2020

BUY
$1.24 - $4.35 $55,878 - $196,024
45,063 New
45,063 $114,000
Q4 2019

Feb 14, 2020

SELL
$2.3 - $5.12 $1.13 Million - $2.51 Million
-491,015 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$4.63 - $12.15 $2.21 Million - $5.81 Million
-478,225 Reduced 49.34%
491,015 $2.27 Million
Q2 2019

Aug 14, 2019

BUY
$11.49 - $14.17 $610,406 - $752,781
53,125 Added 5.8%
969,240 $11.9 Million
Q1 2019

May 15, 2019

BUY
$8.47 - $14.36 $7.33 Million - $12.4 Million
865,653 Added 1715.46%
916,115 $0
Q4 2018

Feb 14, 2019

BUY
$7.18 - $8.83 $127,236 - $156,476
17,721 Added 54.12%
50,462 $434,000
Q3 2018

Nov 13, 2018

BUY
$5.92 - $8.35 $96,827 - $136,572
16,356 Added 99.82%
32,741 $0
Q2 2018

Aug 10, 2018

BUY
$4.86 - $6.24 $20,125 - $25,839
4,141 Added 33.82%
16,385 $0
Q4 2017

Feb 09, 2018

BUY
$4.46 - $6.45 $54,608 - $78,973
12,244
12,244 $72,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.